Udo Schneider

ORCID: 0000-0002-9117-3307
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammatory Myopathies and Dermatomyositis
  • Cannabis and Cannabinoid Research
  • Global Health Care Issues
  • Health and Medical Studies
  • Healthcare Policy and Management
  • Vasculitis and related conditions
  • Eosinophilic Disorders and Syndromes
  • Health Systems, Economic Evaluations, Quality of Life
  • Neurotransmitter Receptor Influence on Behavior
  • Retinal Diseases and Treatments
  • Systemic Sclerosis and Related Diseases
  • Systemic Lupus Erythematosus Research
  • Neuroscience and Neuropharmacology Research
  • Substance Abuse Treatment and Outcomes
  • Muscle Physiology and Disorders
  • Forensic Toxicology and Drug Analysis
  • Obsessive-Compulsive Spectrum Disorders
  • Retinal and Optic Conditions
  • Rheumatoid Arthritis Research and Therapies
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Alcoholism and Thiamine Deficiency
  • Health disparities and outcomes
  • Retinal Imaging and Analysis
  • Immunodeficiency and Autoimmune Disorders
  • Orthopedic Infections and Treatments

Charité - Universitätsmedizin Berlin
2016-2025

Techniker Krankenkasse (Germany)
2011-2025

Humboldt-Universität zu Berlin
2000-2024

Freie Universität Berlin
1978-2024

Universität Hamburg
2005-2024

Tokai University
2024

Tokai University Hospital
2024

University Medical Center Hamburg-Eppendorf
2024

Ruhr University Bochum
2017-2023

Deutscher Wetterdienst
2019-2023

Abstract Objective To investigate the efficacy and tolerability of infliximab therapy for articular dermatologic manifestations active psoriatic arthritis (PsA). Methods One hundred four patients with PsA in whom prior at least 1 disease‐modifying antirheumatic drug (DMARD) had failed were recruited into this investigator‐initiated, multicenter, randomized, double‐blind, placebo‐controlled clinical trial. During initial blinded portion study, received infusions (5 mg/kg) or placebo weeks 0,...

10.1002/art.20967 article EN Arthritis & Rheumatism 2005-04-01

Daratumumab, a human monoclonal antibody that targets CD38, depletes plasma cells and is approved for the treatment of multiple myeloma. Long-lived are implicated in pathogenesis systemic lupus erythematosus because they secrete autoantibodies, but unresponsive to standard immunosuppression. We describe use daratumumab induced substantial clinical responses two patients with life-threatening lupus, sustained by maintenance therapy belimumab, an B-cell activating factor. Significant depletion...

10.1056/nejmoa2023325 article EN New England Journal of Medicine 2020-09-16
Lorenzo Cavagna Ernesto Trallero‐Araguás Federica Meloni Ilaria Cavazzana Jorge Rojas‐Serrano and 95 more Eugen Feist Giovanni Zanframundo Valentina Morandi Alain Meyer José António Pereira da Silva Catarina Costa Øyvind Molberg Helena Andersson Veronica Codullo Marta Mosca Simone Barsotti R Neri Carlo Alberto Scirè Marcello Govoni Federica Furini Francisco Javier López-Longo Julia Martínez‐Barrio Udo Schneider Hanns‐Martin Lorenz Andrea Doria Anna Ghirardello Norberto Ortego‐Centeno Marco Confalonieri Paola Tomietto Nicolò Pipitone Ana Rodriguez Cambron María Ángeles Blázquez-Cañamero Reinhard Voll Sarah K. Wendel Salvatore Scarpato F. Maurier Massimiliano Limonta Paolo Luigi Colombelli Margherita Giannini Bernard Gény Eugenio Arrigoni Elena Bravi Paola Migliorini Alessandro Mathieu Matteo Piga Ulrich Drott Christiane Delbrueck Jutta Bauhammer Giovanni Cagnotto Carlo Vancheri Gianluca Sambataro Ellen De Langhe Pier Paolo Sainaghi Maria Cristina Monti Francesca Gigli Berzolari Mariaeva Romano Francesco Bonella Christof Specker Andreas Schwarting Ignacio Villa Blanco Carlo Selmi Angela Ceribelli Laura Nuño Antonio Mera Nair Pérez Gómez Enrico Fusaro Simone Parisi L. Sinigaglia Nicoletta Del Papa Maurizio Benucci Marco A. Cimmino Valeria Riccieri Fabrizio Conti Gian Domenico Sebastiani Anna Iuliano Giacomo Emmi Daniele Cammelli Marco Sebastiani Andreina Manfredi Javier Bachiller‐Corral Walter Alberto Sifuentes Giraldo Giuseppe Paolazzi Lesley Ann Saketkoo Roberto Giorgi Fausto Salaffi José Manuel Cifrián Roberto Caporali Francesco Locatelli Enrico Marchioni Alberto Pesci Giulia Dei Maria Rosa Pozzi Claudia Lomater Jörg H. W. Distler Johannes Knitza George Schett Florenzo Iannone Marco Fornaro Franco Franceschini Luca Quartuccio

Antisynthetase syndrome (ASSD) is a rare clinical condition that characterized by the occurrence of classic triad, encompassing myositis, arthritis, and interstitial lung disease (ILD), along with specific autoantibodies are addressed to different aminoacyl tRNA synthetases (ARS). Until now, it has been unknown whether presence ARS might affect presentation, evolution, outcome ASSD. In this study, we retrospectively recorded time onset, characteristics, clustering triad findings, survival...

10.3390/jcm8112013 article EN Journal of Clinical Medicine 2019-11-18

1',1'dimethylheptyl-Delta8-tetrahydrocannabinol-11-oic acid (CT-3), a potent analog of THC-11-oic acid, produces marked antiallodynic and analgesic effects in animals without evoking the typical described models cannabinoids. Therefore, CT-3 may be an effective for poorly controlled resistant neuropathic pain.To examine efficacy safety chronic pain humans.Randomized, placebo-controlled, double-blind crossover trial conducted Germany from May-September 2002.Twenty-one patients (8 women 13...

10.1001/jama.290.13.1757 article EN JAMA 2003-09-30

Background: We investigated (1) the prevalence of posttraumatic stress disorder (PTSD) in treatment‐seeking subjects with substance use dependence (SUD), (2) association between comorbid PTSD and severity course addiction psychopathology, (3) this patients subsyndromal PTSD, trauma exposure without PTSD. Methods: In cross‐sectional study, 459 14 German treatment centers participated alcohol‐dependence (A) 39.7%, drug‐dependence (D) 33.6%, or both (AD) 26.8%. The diagnostic measures included...

10.1111/j.1530-0277.2007.00591.x article EN Alcoholism Clinical and Experimental Research 2008-01-30

Article Abstract Background: Preliminary studies suggested that delta-9-tetrahydrocannabinol (THC), the major psychoactive ingredient of Cannabis sativa L., might be effective in treatment Tourette syndrome (TS). This study was performed to investigate for first time under controlled conditions, over a longer-term period, whether THC is and safe reducing tics TS. Method: In this randomized, double-blind, placebo-controlled study, 24 patients with TS, according DSM-III-R criteria, were...

10.4088/jcp.v64n0417 article EN The Journal of Clinical Psychiatry 2003-04-15

Anecdotal reports in Tourette's syndrome (TS) have suggested that marijuana (cannabis sativa) and delta-9-tetrahydrocannabinol (Δ9-THC), the major psychoactive ingredient of marijuana, reduce tics associated behavioral disorders. We performed a randomized double-blind placebo-controlled crossover single-dose trial Δ9-THC (5.0, 7.5 or 10.0 mg) 12 adult TS patients. Tic severity was assessed using self-rating scale (Tourette's Symptom List, TSSL) examiner ratings (Shapiro Severity Scale, Yale...

10.1055/s-2002-25028 article EN Pharmacopsychiatry 2002-04-12

Aims: Attention-deficit/hyperactivity disorder (ADHD) is of great clinical importance not only because its high prevalence but also due to the frequent comorbid illnesses that are connected with this disorder. Several studies were able demonstrate ADHD constitutes a significant risk factor for exacerbation habit-forming illnesses, i.e. addictions. Methods: We conducted study on 152 adult patients alcohol dependence (n = 91) or multiple substance addiction 61) determine whether these affected...

10.1093/alcalc/agn014 article EN Alcohol and Alcoholism 2008-03-07

OBJECTIVE The aim of this study is to provide reliable regression-based estimates costs associated with different type 2 diabetes complications. RESEARCH DESIGN AND METHODS We used nationwide statutory health insurance (SHI) data from 316,220 patients diabetes. Costs for inpatient and outpatient care, pharmaceuticals, rehabilitation, nonmedical aids appliances were assessed in the years 2013–2015. Quarterly observations are available each year. estimated (in 2015 euro) complications using a...

10.2337/dc17-1763 article EN Diabetes Care 2018-01-18

To analyze antisynthetase syndrome-associated myositis by modern myopathologic methods and to define its place in the spectrum of idiopathic inflammatory myopathies (IIMs).Skeletal muscle biopsies from other IIMs different institutions worldwide were analyzed histopathology, quantitative PCR, electron microscopy.Myonuclear actin filament inclusions identified as a unique morphologic hallmark myositis. Nuclear never found dermatomyositis, polymyositis, sporadic inclusion body myositis,...

10.1212/wnl.0000000000001422 article EN Neurology 2015-03-07

Significance Statement Early identification of patients at risk renal flares in ANCA vasculitis is crucial. However, current clinical parameters have limitations predicting relapse accurately. This study investigated the use urinary CD4 + T lymphocytes as a predictive biomarker for vasculitis. study, including urine samples from 102 patients, found that presence cells was robust predictor within 6-month time frame, with sensitivity 60% and specificity 97.8%. The diagnostic accuracy exceeded...

10.1681/asn.0000000000000311 article EN Journal of the American Society of Nephrology 2024-01-17

Journal Article Accepted manuscript Targeting autoimmunity with CD19-CAR T cell therapy: efficacy and seroconversion in diffuse systemic sclerosis rheumatoid arthritis Get access Fredrik N Albach, Albach Department of Rheumatology Clinical Immunology, Charité - Universitätsmedizin Berlin, Germany Search for other works by this author on: Oxford Academic PubMed Google Scholar Ioanna Minopoulou, Minopoulou Artur Wilhelm, Wilhelm GermanyDeutsches Rheuma-Forschungszentrum Robert Biesen, Biesen...

10.1093/rheumatology/keaf077 article EN Lara D. Veeken 2025-02-07

Objective.–To determine whether injections of botulinum toxin could be therapeutic value in the treatment tension‐type headache. Background.–Botulinum A is very effective at reducing muscle tenderness and pain many diseases. Increased tension may contribute to Methods.–We performed a double‐blind, placebo‐controlled study with 21 patients fulfilling International Headache Society criteria for Participants were randomly assigned (pericranial injection 10 × 20 mouse units A) or placebo...

10.1046/j.1526-4610.2000.00044.x article EN Headache The Journal of Head and Face Pain 2000-04-21

Neurotoxicity of first-generation antipsychotics (FGAs) may be involved in lipid peroxidation, which is the pathogenesis extrapyramidal symptoms, including tardive dyskinesia (TD). Blood samples at day 0, 7, and 21 drawn from patients taking were analyzed for malondialdehyde (MDA) plasma, a marker by high-performance liquid chromatography. Of 115 enrolled, 92 completed study. Most MDA levels within normal ranges (<1.0 micromol/liter). Malondialdehyde receiving clozapine (p = 0.002),...

10.1176/jnp.17.2.227 article EN Journal of Neuropsychiatry 2005-05-01

Objective To assess and analyse nutritional status in patients with systemic sclerosis (SSc) identify possible associations clinical symptoms its prognostic value. Methods Body mass index (BMI) parameters of bioelectrical impedance analysis (BIA) were assessed 124 SSc 295 healthy donors matched for sex, age BMI comparisons. In SSc, BIA values compared a cross-sectional study. prospective open analysis, survival changes the energy uptake induced by treatment evaluated. Results Patients had...

10.1136/ard.2009.123273 article EN Annals of the Rheumatic Diseases 2010-05-28

Diffuse myofiber necrosis in the context of inflammatory myopathy is hallmark immune-mediated necrotizing (IMNM). We have previously shown that skeletal muscle fibers IMNM patients may display nonrimmed vacuoles and sarcoplasmic irregularities. The dysfunctional chaperone activity has been linked to defective assembly proteins their degradation via lysosomes, autophagy proteasomal machinery. This study was undertaken highlight a chaperone-assisted selective (CASA) pathway, functionally...

10.1111/bpa.12772 article EN Brain Pathology 2019-08-03

Suboptimal patient adherence to pharmacological therapy of type 2 diabetes may be due in part pill burden. One way reduce burden patients who need multiple medications is use fixed-dose combinations. Our study aimed compare the effects combination versus loose-dose on medication and persistence, health care utilization, therapeutic safety, morbidities, treatment modification with over three years.

10.1371/journal.pone.0250993 article EN cc-by PLoS ONE 2021-05-04
Coming Soon ...